Previous evidence suggested that depleting Treg cells using antibodies against Treg markers (CTLA-4 and OX40) at a single tumor site could generate a systemic anti-tumor response that eliminated disseminated metastatic tumor cells[162]. Here, CTLA4 is linked to neoplasm.